HB-EGF promotes epithelial cell migration in eyelid development

Development

Volumn 132, Issue 19, 2005, Pages 4317-4326

  Mine, Naoki ^a   Iwamoto, Ryo ^a   Mekada, Eisuke ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

EGFR; Epithelial cell migration; ERK; Eyelid; HB EGF; Leading edge; Mouse; TGF

Indexed keywords

ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; EPITHELIUM CELL; EYE DEVELOPMENT; EYELID; EYELID CLOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; EYELIDS; MICE; MICE, KNOCKOUT; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMALIA;

EID: 27644556565     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.02030     Document Type: Article

References (48)

1. Du, X., Tabeta, K., Hoebe, K., Liu, H., Mann, N., Mudd, S., Crozat, K., Sovath, S., Gong, X. and Beutler, B. (2004). Velvet, a dominant Egfr mutation that causes wavy hair and defective eyelid development in mice. Genetics 166, 331-340.
2. Elenius, K., Paul, S., Allison, G., Sun, J. and Klagsbrun, M. (1997). Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16, 1268-1278.
3. Findlater, G. S., McDougall, R. D. and Kaufman, M. H. (1993). Eyelid development, fusion and subsequent reopening in the mouse. J. Anat. 183, 121-129.
4. Fowler, K. J., Walker, F., Alexander, W., Hibbs, M. L., Nice, E. C., Bohmer, R. M., Mann, G. B., Thumwood, C., Maglitto, R., Danks, J. A. et al. (1995). A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92, 1465-1469.
5. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E. and Taniguchi, N. (1995). Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6, 967-980.
6. Grose, R. (2003). Epithelial migration: open your eyes to c-Jun. Curr. Biol. 13, R678-R680.
7. Harris, M. J. and Juriloff, D. M. (1986). Eyelid development and fusion induced by cortisone treatment in mutant, lidgap-Miller, foetal mice. A scanning electron microscope study. J. Embryol. Exp. Morphol. 91, 1-18.
8. Harris, R. C., Chung, E. and Coffey, R. J. (2003). EGF receptor ligands. Exp. Cell Res. 284, 2-13.
9. Hashimoto, K., Higashiyama, S., Asada, H., Hashimura, E., Kobayashi, T., Sudo, K., Nakagawa, T., Damm, D., Yoshikawa, K. and Taniguchi, N. (1994). Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 269, 20060-20066.
10. Hayashi, Y., Liu, C.-Y., Jester, J. J., Hayashi, M., Wang, I.-J., Funderburgh, J. L., Saika, S., Roughley, P. J., Kao, C. W.-C. and Kao, W. W.-Y. (2005). Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-α signaling. Dev. Biol. 277, 222-234.
11. Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C. and Klagsbrun, M. (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251, 936-939.
12. Holbro, T. and Hynes, N. E. (2004). ErbB receptors: directing key signaling networks through life. Annu. Rev. Pharmacol. Toxicol. 44, 195-217.
13. Iwamoto, R. and Mekada, E. (2000). Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11, 335-344.
14. Iwamoto, R., Senoh, H., Okada, Y., Uchida, T. and Mekada, E. (1991). An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor. J. Biol. Chem. 266, 20463-20469.
15. Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G. et al. (2003). Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 100, 3221-3226.
16. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S. et al. (1998). A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260-7272.
17. Jackson, L. F., Qiu, T. H., Sunnarborg, S. W., Chang, A., Zhang, C., Patterson, C. and Lee, D. C. (2003). Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22, 2704-2716.
18. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P., Ward, C. W. and Burgess, A. W. (2003). Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284, 31-53.
19. Kiguchi, K., Bol, D., Carbajal, S., Beltran, L., Moats, S., Chan, K., Jorcano, J. and DiGiovanni, J. (2000). Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Oncogene 19, 4243-4254.
20. Lee, D. C., Sunnarborg, S. W., Hinkle, C. L., Myers, T. J., Stevenson, M. Y., Russell, W. E., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A. et al. (2003). TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. New York Acad. Sci. 995, 22-38.
21. Li, C., Guo, H., Xu, X., Weinberg, W. and Deng, C. X. (2001). Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning. Dev. Dyn. 222, 471-483.
22. Li, G., Gustafson-Brown, C., Hanks, S. K., Nason, K., Arbeit, J. M., Pogliano, K., Wisdom, R. M. and Johnson, R. S. (2003). c-Jun is essential for organization of the epidermal leading edge. Dev. Cell 4, 865-877.
23. Luetteke, N. C., Qiu, T. H., Peiffer, R. L., Oliver, P., Smithies, O. and Lee, D. C. (1993). TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73, 263-278.
24. Luetteke, N. C., Phillips, H. K., Qiu, T. H., Copeland, N. G., Earp, H. S., Jenkins, N. A. and Lee, D. C. (1994). The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8, 399-413.
25. Luetteke, N. C., Qiu, T. H., Fenton, S. E., Troyer, K. L., Riedel, R. F., Chang, A. and Lee, D. C. (1999). Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739-2750.
26. Massague, J. and Pandiella, A. (1993). Membrane-anchored growth factors. Annu. Rev. Biochem. 62, 515-541.
27. Matsubayashi, Y., Ebisuya, M., Honjoh, S. and Nishida, E. (2004). ERK activation propagates in epithelial cell sheets and regulates their migration during wound healing. Curr. Biol. 14, 731-735.
28. Miettinen, P. J., Berger, J. E., Meneses, J., Phung, Y., Pedersen, R. A., Werb, Z. and Derynck, R. (1995). Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376, 337-341.
29. Piepkorn, M., Pittelkow, M. R. and Cook, P. W. (1998). Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J. Invest. Dermatol. 111, 715-721.
30. Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G. and Shoyab, M. (1993). Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 90, 1746-1750.
31. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C. and Ullrich, A. (1999). EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884-888.
32. Raab, G. and Klagsbrun, M. (1997). Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta. 1333, F179-F199.
33. Sahin, U., Weskamp, G., Kelly, K., Zhou, H. M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P. and Blobel, C. P. (2004). Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769-779.
34. Shirakata, Y., Kimura, R., Nanba, D., Iwamoto, R., Tokumaru, S., Morimoto, C., Yokota, K., Nakamura, M., Sayama, K., Mekada, E. et al. (2005). Heparin-binding EGF-like growth factor accelerates keratinocyte migration in skin wound healing. J. Cell Sci. 118, 2363-2370.
35. Sibilia, M. and Wagner, E. F. (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238.
36. Takenobu, H., Yamazaki, A., Hirata, M., Umata, T. and Mekada, E. (2003). The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades. J. Biol. Chem. 278, 17255-17262.
37. Tanno, S., Ohsaki, Y., Nakanishi, K., Toyoshima, E. and Kikuchi, K. (2004). Small cell lung cancer cells express EGFR and tyrosine phosphorylation of EGFR is inhibited by gefitinib ('Iressa', ZD1839). Oncol. Rep. 12, 1053-1057.
38. Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C. et al. (1995). Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269, 230-234.
39. Umata, T., Hirata, M., Takahashi, T., Ryu, F., Shida, S., Takahashi, Y., Tsuneoka, M., Miura, Y., Masuda, M., Horiguchi, Y. and Mekada, E. (2001). A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 276, 30475-30482.
40. Von Pawel, J. (2004). Gefitinib (Iressa, ZD1839): a novel targeted approach for the treatment of solid tumors. Bull. Cancer 91, E70-E76.
41. Weston, C. R., Wong, A., Hall, J. P., Goad, M. E., Flavell, R. A. and Davis, R. J. (2004). The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis. Proc. Natl. Acad. Sci. USA 101, 14114-14119.
42. Wong, R. W. (2003). Transgenic and knock-out mice for deciphering the roles of EGFR ligands. Cell. Mol. Life Sci. 60, 113-118.
43. Xia, Y. and Kao, W. W. (2004). The signaling pathways in tissue morphogenesis: a lesson from mice with eye-open at birth phenotype. Biochem. Pharmacol. 68, 997-1001.
44. Xia, Y. and Karin, M. (2004). The control of cell motility and epithelial morphogenesis by Jun kinases. Trends. Cell Biol. 14, 94-101.
45. Xian, W., Rosenberg, M. P. and DiGiovanni, J. (1997). Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion. Oncogene 14, 1435-1444.
46. Yamazaki, S., Iwamoto, R., Saeki, K., Asakura, M., Takashima, S., Yamazaki, A., Kimura, R., Mizushima, H., Moribe, H., Higashiyama, S. et al. (2003). Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol. 163, 469-475.
47. Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M. and Wagner, E. F. (2003). c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 4, 879-889.
48. Zhang, L., Wang, W., Hayashi, Y., Jester, J. V., Birk, D. E., Gao, M., Liu, C. Y., Kao, W. W., Karin, M. and Xia, Y. (2003). A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. EMBO J. 22, 4443-4454.